Search
  • 網站搜尋
亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。
返回搜索結果

Engineered Respiratory Syncytial Viruses with Control of Cell-to-Cell Virus Transmission for Enhanced Safety of Live Virus Vaccines


總結

OSU researchers have developed a method to control the rate of cell-to-celltransmission of human RSV, making it possible to tailor vaccines to thestrength each person needs for maximum protection without side effects.  The method also allows for the creation of anon-functional RSV which could be used for immunocompromised patients whorequire more stringent safety conditions. The vaccine created from this method would be easy to produce sincethere is no need to for weakened RSV.


技術優勢

Virus cell to cell transmission can be blocked entirely or fine-tuned to different levels Improved vaccine safety Higher antigen production, recognition, and efficacy Easier production than attenuated viruses Controlled spread of virus without negative side effects


技術應用

Prevention of human RSV outbreaks


詳細技術說明

None


國家/地區

美國

欲了解更多信息,請點擊 這裡
Business of IP Asia Forum
桌面版